Business description
Boundless Bio is the company dedicated to treating oncogene amplified cancers and is the leader in the field of ecDNA, driving the discovery and development of a novel therapeutic approach to targeting oncogene amplified cancers.
Management board & Supervisory board
| CEO |
| Zachary Hornby |
| Management board |
| Jami Rubin, Neil Abdollahian, Amy Berkley, Chris Hassig, David Hinkle, Shailaja Kasibhatla, Peter Krein, Jessica Oien, Anthony “Tony” Pinkerton, Klaus Wagner, Meredith Wesley, Sara Weymer |
| Supervisory board |
| Jonathan Lim, Christine Brennan, Kristina Burow, James “Jamie” Christensen,, Zachary Hornby, Jennifer Lew, Nancy Whiting |
Company data
| Name: |
Boundless Bio Inc. |
| Address: |
9880 Campus Point Dr, Suite 120,San Diego, CA 92121 |
| Phone: |
858-766-9912 |
| Fax: |
- |
| E-mail: |
partnerships@boundlessbio.com
|
| Internet: |
https://boundlessbio.com/ |
| Industry: |
Biotechnology |
| Sector: |
Biotechnology |
| Sub sector: |
Biotechnology |
| End of financial year: |
31/12 |
| Free Float: |
- |
| IPO date: |
28/03/2024 |
